Comprehensive Laboratory Evaluation Baseline bloodwork is ordered to assess hormonal function, inflammatory markers, immune status, and metabolic health
For instance, in October 2024, Novo Nordisk made significant strides with Rybelsus, as the company announced its plan to expand the drugs indication to prevent major adverse cardiovascular events (MACE) in patients with Type 2 diabetes, cardiovascular disease (CVD), or chronic kidney disease (CKD)
Nutritional Support Made Simple for GLP-1 Wellness Everything you need to know about staying nourished, energized, and supported while on GLP-1 therapies
Monitoring Is Not Optional The fourth principle is that this level of biological ambition requires a correspondingly rigorous approach to monitoring
DOI: 10.1046/j.1471-4159.1998.71020705.x 32
They summoned Dr